Suzhou Alphamab Co., Ltd.

This study tests a new medicine called KN057 given regularly to prevent bleeding episodes in people with hemophilia A or B, including those whose bodies have developed resistance to standard treatments. About 70 males aged 12 to 65 will receive weekly injections for up to 52 week…

This early-stage study tests a new drug, KN060, for people with high blood pressure (hypertension). About 60 adults will receive either KN060 or a placebo by IV every two weeks for 12 weeks. The goal is to see if KN060 safely lowers blood pressure compared to placebo.

This early-stage study tests a drug called KN060 in 12 adults with end-stage kidney disease who are on regular hemodialysis. The goal is to see if the drug is safe and can prevent blood clots in the dialysis machine and the patient's access site. Participants receive the drug eve…

This early-stage study tests a new drug called KN069 in 36 Chinese men who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor weight, waist size…